Stock Events

Stock Events

Ab Science

€1.19

0

-€0.01-0.67% Friday 19:32

Statistics

Day High

1.2

Day Low

1.18

52W High

1.66

52W Low

1.09

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

1JanExpected

Q4 0

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow A8D.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that competes with AB Science in the development of treatments for various diseases, including those in oncology and inflammatory diseases, areas where AB Science is also active.

Novartis is a global healthcare company that competes across multiple segments, including those targeted by AB Science, such as cancer and chronic inflammatory diseases, with a broad portfolio of drugs.

Amgen is a biotech company focusing on human therapeutics, with products that compete in the oncology and inflammatory disease markets, directly competing with AB Science's research and drug development efforts.

Pfizer is a research-based biopharmaceutical company with a wide range of products that compete with AB Science, especially in the fields of oncology and immunology.

Roche Holding AG is a healthcare company that competes with AB Science in developing treatments for various diseases, including cancer and chronic inflammatory conditions, through its biotechnology and pharmaceutical divisions.

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with AB Science's portfolio, especially in cancer and immune-inflammatory diseases.

Merck & Co., Inc. is known for its contributions to healthcare and pharmaceuticals, competing with AB Science in areas such as oncology, making it a direct competitor in the development of cancer treatments.

Eli Lilly and Company is a global pharmaceutical company that develops drugs in areas like oncology and autoimmune diseases, competing with AB Science in the development and marketing of treatments for similar conditions.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a biotechnology company that competes with AB Science in the development of medicines for the treatment of serious medical conditions, including oncology and inflammatory diseases.

AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of therapeutic products, competing with AB Science in areas such as oncology and respiratory diseases.

About

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

Show more...

CEO

Mr. Alain Moussy MBA

Employees

40

Country

France

ISIN

FR0010557264

Listings

0 Comments

Share your thoughts

FAQ

What is Ab Science stock price today?▼

The current price of A8D.STU is €1.19 EUR — it has decreased by -0.67% in the past 24 hours. Watch Ab Science stock price performance more closely on the chart.

What is Ab Science stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Ab Science stocks are traded under the ticker A8D.STU.

Is Ab Science stock price growing?▼

A8D.STU stock has risen by +1.02% compared to the previous week, the month change is a -4.19% fall, over the last year Ab Science has showed a -5.86% decrease.

How many employees does Ab Science have?▼

As of April 12, 2026, the company has 40 employees.

In which sector is Ab Science located?▼

Ab Science operates in the Health & Wellness sector.

When did Ab Science complete a stock split?▼

Ab Science has not had any recent stock splits.

Where is Ab Science headquartered?▼

Ab Science is headquartered in Paris, France.